HST Global Inc. Equity Repurchase (Common, Net)

Equity Repurchase (Common, Net) of HSTC for past 10 years: annual, quarterly and twelve month trailing (TTM) including Equity Repurchase (Common, Net) growth rates and interactive chart.

Highlights and Quick Summary

  • Equity Repurchase (Common, Net) for the quarter ending December 30, 2019 was $0 (a -100.0% decrease compared to previous quarter)
  • Annual Equity Repurchase (Common, Net) for 2019 was $80 Thousand (a -78.74% decrease from previous year)
Visit stockrow.com/HSTC for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Equity Repurchase (Common, Net) of HST Global Inc.

Most recent Equity Repurchase (Common, Net)of HSTC including historical data for past 10 years.

Interactive Chart of Equity Repurchase (Common, Net) of HST Global Inc.

HST Global Inc. Equity Repurchase (Common, Net) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2019 $0.0 $0.08 $0.08
2009 $0.38 $0.38

Business Profile of HST Global Inc.

Sector: Medical
Industry: Drugs
HST Global, Inc., an integrated health and wellness biotechnology company, develops and/or acquires a network of wellness centers for the homeopathic and alternative treatment of late stage cancer worldwide. It also focuses on the homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late stage cancers and other life threatening diseases. The company also intends to acquire products for the treatment of individual health challenges. HST Global, Inc. is headquartered in Hampton, Virginia.